Search - tctmd.com

Displaying 221 - 240 of 246

Sort: Relevancy | Date

News Daily News

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

Yael L. Maxwell

October 11, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

July 15, 2011

News Daily News

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

June 24, 2011

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

News Daily News

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

L.A. McKeown

May 03, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Conference News

RAPS: Radial Arteries Superior to Saphenous Vein Grafts at 5 Years After CABG

Caitlin E. Cox

April 13, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

News Daily News

Study Compares Stents, Surgery in Diabetics with Multivessel Disease

Caitlin E. Cox

March 23, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

February 07, 2011

Advertisement

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Novel Anticoagulants Showing Benefits in A-fib Subgroups

New-Generation DES Reduce Restenosis, Stent Thrombosis

Women Have Less Neointimal Hyperplasia Than Men With ZES

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

Paclitaxel Balloon Maintains Advantage at 5 Years

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

RAPS: Radial Arteries Superior to Saphenous Vein Grafts at 5 Years After CABG

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Study Compares Stents, Surgery in Diabetics with Multivessel Disease

Studies Support DES Use in Diabetics, But Results Vary by Device

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content